Graves Eye Disease and Periorbital HOF
- Muscle
- Highlighted area
Quick facts
- Condition
- Autoimmune thyroid disease affecting the orbits
- Signs on the face
- Eyelid retraction, periorbital swelling, prominent eyes, redness
- Principle
- Periorbital area only with clearance and ophthalmology follow-up
- Phase matters
- Active and stable disease call for very different approaches
Eye disease associated with Graves disease, also called thyroid orbitopathy, is one of the conditions that calls for the most humility in the HOF practice. The patient arrives with a legitimate aesthetic complaint: a "startled" look, bags, puffiness around the eyes, under-eye circles. The professional sees retracted eyelids, exposed sclera and swelling, and the temptation is to treat the appearance. But in this case, the appearance is a symptom of a disease that affects the orbit, and what looks aesthetic may be clinical.
This page is a review for professionals, not a protocol. It has no doses or injection technique, and no decision here replaces the assessment of the ophthalmologist and the endocrinologist. The context of diseases that show up on the face is in general contraindications in HOF and in autoimmune diseases and fillers.
What is Graves eye disease?
It is an autoimmune disease in which the immune system attacks tissues in the orbit, usually in people with Graves disease (autoimmune hyperthyroidism), although it can also appear with the thyroid under control or, more rarely, with normal function. The inflammatory process increases the volume of the orbital tissues, including muscles and fat, which pushes the eyeball forward and changes how the eyelids work.
The disease has an active phase, with inflammation, and a stable phase, in which activity decreases but sequelae may remain. This concept is central: the same patient may be a candidate for one approach in one phase and contraindicated in another.
What signs can the HOF professional notice?
You do not diagnose, but you can notice signs that justify a referral.
| Sign | What it may indicate | Attention |
|---|---|---|
| Eyelid retraction | Upper or lower eyelid higher or lower than usual, sclera visible above or below the iris | "Wide-eyed" look |
| Proptosis (prominent eyes) | Forward projection of the globe | Can accentuate the look of bags and dark circles |
| Periorbital swelling | Puffy eyelids, worse on waking | Mistaken for bags and ordinary swelling |
| Redness and swelling of the conjunctiva | Active inflammation | Sign of the active phase |
| Difficulty closing the eye | Corneal exposure | There may be lagophthalmos |
| Double vision or limited movement | Involvement of the eye muscles | Symptom that requires an ophthalmologist |
| Recent, rapid worsening | Possible activity | Referral priority |
If any of these signs appears in a patient with no known diagnosis, the path is referral, not filler. A "strange" look of recent onset may be the first manifestation of a disease she does not yet know she has.
Why does the periorbital area call for caution?
Anatomy and pathophysiology add up.
- Swelling and retraction make assessment harder. The volume and position of the eyelids change with disease activity, so today's clinical measurement may not hold in a few weeks.
- Filling bags and grooves can worsen the appearance. If part of the complaint comes from swelling and proptosis, adding volume tends to accentuate the look of bulging eyes and bags. See periorbital anatomy for injectables.
- Corneal exposure already exists or is imminent. Procedures that change eyelid tone can worsen dryness. See dry eye and lagophthalmos after toxin and ectropion and eyelid retraction after a procedure.
- Signs can be masked. An aesthetic treatment can delay recognition of disease activity.
- There is vascular risk in the area. The periorbital area is already considered an area of caution, as in vascular occlusion in the infraorbital region.
- The patient may be in treatment with corticosteroids, radiotherapy or other measures, which change the context.
In practical terms, treating the eye area of someone with active Graves, without clearance, is an approach that reviews generally advise against. In the stable phase, the decision is shared and individualized.
What about the other areas of the face?
The disease is orbital, and many treatments in other areas can be considered, with the caveat that overall health matters. A patient with poorly controlled hyperthyroidism, for example, may have palpitations, anxiety and tremor that deserve attention before any procedure. Practical points:
- Controlled thyroid disease makes it easier to assess overall risk. Ask about the latest test and the follow-up.
- Areas far from the eyes, such as the chin, jaw and lips, are usually discussed with fewer restrictions, always at the professional's discretion and according to the clinical condition.
- Forehead and glabella need more attention, because of their proximity to the orbit and the effect of toxin on brow and eyelid position.
- Threads, energy devices and other resources in the periorbital area call for specific clearance.
Suggested routine at the visit
A short flow organizes the reasoning.
- In the medical history, ask about thyroid disease, current treatment, follow-up with an endocrinologist and ophthalmologist, orbital surgery and radiotherapy. See medical history in HOF.
- Observe the face at rest, with the patient looking straight ahead: eyelid position, visible sclera, prominence and swelling.
- Photograph to the practice's standard. See standardized clinical photography.
- Ask about symptoms: burning, grittiness, double vision, pain, recent changes.
- If there is suspicion or a diagnosis, request an ophthalmologist's assessment before any periorbital procedure and record the decision in the patient record.
- If clearance is given, agree on modest goals and on what will be avoided.
- Document the conversation and the consent.
How to communicate without frustrating
The patient has often lived for a long time with a look that bothers her, and hearing "no" to the procedure can sound like rejection. The way you communicate takes care of that.
Present the referral as care, not as refusal. Stress that you will follow up and pick the conversation back up once clearance is given. If the patient declines, record it. The referral flow is in patient referral in HOF.
After orbital surgery or treatment
Patients who have had orbital decompression, eyelid surgery or strabismus surgery have altered anatomy, with scars, changed tissue planes and lower predictability. In these cases, assessment requires looking at the surgical history and, again, involving the ophthalmologist. See also harmonization after blepharoplasty for general reasoning in operated eyes.
In Harmy
Summary
In Graves eye disease, the look of the eyes is a manifestation of disease. Recognize the signs, ask about symptoms, do not treat the periorbital area without clearance from the ophthalmologist and the endocrinologist, and respect the phase of the disease. Communicate the referral as care, record everything and keep following up. The other areas of the face can be managed case by case, always keeping the clinical picture in mind.
Frequently asked questions
Can someone with Graves eye disease have facial harmonization?
Yes, but the periorbital area calls for caution and, in general, clearance from the ophthalmologist and the endocrinologist. Other areas of the face can be assessed case by case, with the disease under control.
Why is the eye area sensitive in these patients?
Because the disease alters the orbit, the eyelids and the eye muscles: there is eyelid retraction, swelling and prominent eyes. Procedures in this area can mask signs, worsen corneal exposure or be mistaken for disease progression.
Is botulinum toxin safe for people with Graves?
It depends on the area and the phase of the disease. Around the eye, weakening the orbicularis can worsen corneal exposure. The decision should involve the ophthalmologist, who knows the patient's eyelid function.
How do I know whether the disease is active or stable?
That classification is medical and is based on clinical criteria from the ophthalmologist and the endocrinologist, such as inflammatory signs and progression. The HOF professional should not infer the phase alone, but ask for the assessment.
Harmy images are illustrative simulations generated by AI from the patient's photo to support the conversation between practitioner and patient. They are not a promise of results. Indication, technique, product and volume are solely the decision of the licensed practitioner. This content is for information only and does not replace a clinical assessment.